Prasol Chemicals Confirms Nil Deviation in IPO Proceeds Utilization for Sep'26 Quarter
Prasol Chemicals Ltd 路 Others (Uncategorized) 路 03 Nov 2026, 2:56 am
Prasol Chemicals Confirms Nil Deviation in IPO Proceeds Utilization for Sep'26 Quarter Prasol Chemicals Limited reported no deviation or variation in the utilization of funds raised via its Initial Public Offering for the quarter ended 30th Sep'26, as per SEBI LODR Regulation 32. The company raised Rs 800 million through the public issue, with the allotment completed on 11th Sep'26. Fund deployment remains aligned with the stated objects outlined in its prospectus dated 10th Sep'26, with nil adverse comments from the Audit Committee or statutory auditors.
Original exchange filing (PDF)
More announcements from Prasol Chemicals Ltd
- Intimation of Annual Investor Conference 路 07 Nov 2026
- Outcome of Quarterly Earnings Conference Call- Call recording for Q2FY27 results 路 03 Nov 2026
- Announcement under Regulation 30 (LODR) - Presentation of Quarterly Earnings Conference Call for Q2FY27 Results 路 03 Nov 2026
- Prasol Chemicals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 03 Nov 2026
- Financial Results For The Quarter And Half Year Ended September 30, 2026 路 03 Nov 2026
- Board Meeting Outcome for Unaudited Standalone Financials Results For The Quarter And Half Year Ended September 30, 2026 路 03 Nov 2026
- Intimation of Schedule of Q2 FY27 Earnings Conference Call 路 03 Nov 2026
- To consider and approve, inter-alia, the Un-audited Financial Results along with Limited Review Report for the quarter and half year ended September 30, 2026 路 02 Nov 2026
